Navigation Links
Aeolus Pharmaceuticals To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
Date:4/18/2013

New York, NY (PRWEB) April 18, 2013

Taglich Brothers, Inc. is pleased to announce that John McManus, President & CEO and Russell Skibsted, CFO of Aeolus Pharmaceuticals (OTCQB: AOLS) will be presenting at their 10th Annual Small Cap Equity Conference May 7, 2013. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich Brothers at 212-779-2971 or visit http://www.TaglichBrothers.com.

About Taglich Brothers:
Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.

About Aeolus Pharmaceuticals:
Aeolus Pharmaceuticals is developing a platform of a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Department of Health and Human Services, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology,
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Radiopharmaceuticals Market - New Industry Research Report Published by Transparency Market Research
2. Sewage lagoons remove most -- but not all -- pharmaceuticals
3. Blue Door Pharma and Global Energy Markets Strike Global Export Agreement for Meningitis Vaccine and Pharmaceuticals
4. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
5. Environmentally friendly chemistry important for manufacturing pharmaceuticals
6. Scientists use sound waves to levitate liquids, improve pharmaceuticals
7. Healthcare Solutions, Cox Enterprises and Broadspire to Present at RIMS 2013
8. Quorum Review IRB Presents on Good Clinical Practice Essentials at MAGI’s 2013 Clinical Research Conference
9. Johns Hopkins experts to present genetics advances at international meeting this weekend
10. From Hydro Med Inc: New Therapy for Tinnitus to be presented April 15. It’s the ability of a Patient to Show their Tinnitus
11. Altec Joins Sage Customer Symposiums in the Mid-West to Present the Benefits of Integrated Document Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Graphics, coding, typography and search engine optimization– ... of web design and require thorough knowledge to create ... to create a website can be as easy as ... reviews and Facebook posts all accumulate on a multiple ... evolution of how a business can develop a website," ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Paramount Rx, ... care, is increasing efforts to help people save money ... continue to increase for prescription drugs in the new ... savings and resources to bridge the relationship between consumers, ... of the biggest challenges people face today with medical ...
(Date:10/30/2014)... 2014 Home Care Assistance – Halton/Peel ... non-medical, in-home senior care, is weighing in on a ... , The study, performed by the University of Illinois, ... 78 over a week-long period and observed how much ... activity. By examining the structural soundness of the white ...
(Date:10/30/2014)... Newport Beach, California (PRWEB) October 30, 2014 ... superfood nutrtion bars are now available through a unique ... an online site designed to empower the everyday athlete. ... the worlds best athletes and created a system to ... really excited to see REV’D® is now available on ...
(Date:10/30/2014)... 2014 (HealthDay News) -- When it comes to heart disease, ... to delay care when they have symptoms that spell trouble. ... the hospital with a more severe or advanced stage of ... author Catherine Kreatsoulas, a Fulbright Scholar and research fellow at ... release from the Heart and Stroke Foundation of Canada. ...
Breaking Medicine News(10 mins):Health News:Facebook Websites In Thirty-Seconds 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Women Often Ignore Signs of Heart Trouble 2
... action for the public, health professionals, the food industry and ... sodium (salt) Americans consume daily. , In an advisory, ... , the association sets out the science behind the American ... consume no more than 1500 milligrams (mg) of sodium a ...
... HealthDay Reporter , THURSDAY, Jan. 13 (HealthDay News) -- ... "Together We Thrive: Tucson and America" memorial, President Barack Obama ... visit with her and her husband Mark Kelly at University ... An aide to House Minority Leader Nancy Pelosi (D-Calif.) ...
... plenty of natural light and artwork may seem like unaffordable ... and design features can improve patient care and in the ... elements of the "Fable hospital," an ideal health care facility ... design. Elements of the Fable hospital are being adopted on ...
... motion in living cells may help researchers shed light ... according to Ning Fang, an associate scientist at the ... at Iowa State University. ... in Engineered Environments and Live Cells with Gold Nanorods ...
... shows that oncolytic viruses, which are engineered to destroy ... brain tumors if equipped with an enzyme that helps ... the cancer-killing virus clear its way through the thickets ... impede the virus,s movement through the tumor, say researchers ...
... -- Bottle rockets can cause serious eye injuries to children ... warns. Researchers at Vanderbilt University Medical Center in Nashville, ... aged 18 or younger, who suffered eye injuries caused by ... patients were injured while launching bottle rockets and two were ...
Cached Medicine News:Health News:Population-wide reduction in salt consumption recommended 2Health News:Population-wide reduction in salt consumption recommended 3Health News:Giffords Opens Eyes. Like 'Watching a Miracle,' Friends Say 2Health News:Giffords Opens Eyes. Like 'Watching a Miracle,' Friends Say 3Health News:Next-generation hospital design can improve health -- and save money 2Health News:New tool for cell research may help unravel secrets of disease 2Health News:Virus might fight brain tumors better if armed with bacterial enzyme, study shows 2Health News:Bottle Rockets Can Cause Serious Eye Injuries in Kids 2
(Date:10/30/2014)... -- , Extensively hydrolyzed milk formula with LGG ... Cow milk protein allergy (CMPA) is the leading cause of food ... has been managed by eliminating milk proteins from a ... is possible to help build of oral tolerance to ... the first year of life by using an extensively ...
(Date:10/30/2014)... , Oct. 29, 2014 nebulizer is a ... (asthma, COPD and cystic fibrosis) that converts liquid medication ... reach into the lungs of a patient when inhaled ... nebulizers market is dominated by various devices powered by ... prevalence of asthma, COPD and cystic fibrosis and growing ...
(Date:10/30/2014)... LOS ANGELES , Oct. 29, 2014 /PRNewswire/ ... pharmaceutical company devoted to bringing new products to ... 2015. ViaDerma has developed an innovative, ... for rapid mass transfer of pharmaceutical active ingredients ... to provide immediate localized therapy. The transdermal delivery ...
Breaking Medicine Technology:Experts Present Latest Research at Allergy Day 2Experts Present Latest Research at Allergy Day 3Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
... at American College of Rheumatology Annual Congress -, ... BMY ) today announced the results of ... that showed ORENCIA(R) (abatacept) improved daily,activity participation, such ... and sleep quality in adult rheumatoid arthritis,(RA) patients ...
... Ophthalmology Annual Meeting Describes ... in Treatment of Endothelial Disease, NEW ORLEANS, Nov. ... Academy of Ophthalmology,s Annual Meeting, Massimo Busin,MD, department head ... Italy, described a technique that significantly improved,results in patients ...
Cached Medicine Technology:Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 2Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 3Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 4Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 5Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 6Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 7Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 8Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept) 9Improved Cornea Surgery Technique Provides Enhanced Transplant Success 2
Provides stable positioning of a patient during hip surgery. Multi-adjustment arms allow the positioner to be adjusted to fit all sizes of patients. Especially helpful with large patients where reach...
Interphlex Flexible Stablization Rods offer correction of Hammer Toes with a High level of Flexibility while maintaining correct toe length and shape....
The Continuous Wave II Arthroscopy Pump provides pulse-free, continuous fluid inflow for joint distention when used in conjunction with a high flow sheath or separate inflow cannula....
True/Fix Distal Femoral Nail System...
Medicine Products: